Denali Therapeutics Inc. (DNLI)
12.80
-0.94 (-6.84%)
At close: Apr 03, 2025, 3:59 PM
12.40
-3.12%
Pre-market: Apr 04, 2025, 07:06 AM EDT
13F Institute Ownership
Total Institutes of 228 in Denali Therapeutics expanded their positions with an increase of 7 investors compared to the previous quarter. An additional 1.58M shares, as total invested capital declined by $1.07B with ownership percentage increasing from 74.57% to 75.50%.
Options Activity
Institutions are holding more Calls Contracts as Puts Contracts, indicating a bullish sentiment.
Put/Call 0.583
0.58
Call Flow 63,100
63%
Put Flow 36,800
37%
Top Shareholders
| Institute | Ownership | Shares | Shares % Change | Market Value | Portfolio |
|---|---|---|---|---|---|
| Blackrock, Inc. | 8.21% | 13.92M | +0.96% | 283.69M | < 0.01% |
| Baillie Gifford & Co | 7.27% | 12.31M | -7.73% | 250.96M | 0.19% |
| Vanguard Group Inc | 7.09% | 12.02M | +7.55% | 244.99M | < 0.01% |
Trade Smarter, Not Harder
Cut through market noise with actionable insights that actually help you make confident investment decisions. No more endless research or gut-based guessing.
- Unlimited access to all data and tools
- Unlimited access to all data and tools, giving you the edge over everyone else in the market.
- Realtime Options & Dark Pool Data
- Instant access to live options & dark pool data to spot opportunities and trade with precision before the market moves.
- Top Wallstreet Analyst Ratings
- Follow ratings from the best analysts on Wall Street to stay ahead.
- Up to 30 years financial history
- We deliver premium Wall Street data with top-tier accuracy and up to 30 years of history.